|
|
抗合成酶综合征合并肺曲霉菌感染1报道及文献复习
|
Abstract:
抗合成酶综合征(Anti Synthetase Syndrome, ASS)是一种自身免疫病，常累及肺部，临床发病早期常不典型，容易与肺部感染混淆，导致延迟诊断、漏诊，且因宿主因素在诊治过程中易合并重症或特殊病原学感染导致诊治困难，预后不良。本文通过总结我院成功救治的1例ASS合并肺曲霉菌感染病例的诊治过程及经验教训，以期提高临床医师对ASS合并肺曲霉菌感染的诊治思路。
Anti synthetase syndrome (ASS) is an autoimmune disease that often affects the lungs. In the early stages of clinical onset, it is often atypical and easily confused with lung infections, leading to delayed diagnosis and missed diagnosis. Moreover, due to host factors, it is prone to be complicated with severe or special pathogenic infections during the diagnosis and treatment process, resulting in difficult diagnosis and poor prognosis. This article summarizes the diagnosis and treatment process and lessons learned from a successful case of ASS complicated with pulmonary aspergillosis infection treated in our hospital, in order to improve clinical physicians’ diagnosis and treatment ideas for ASS complicated with pulmonary aspergillosis infection.
| [1] | Connors, G.R., Christopher-Stine, L., Oddis, C.V. and Danoff, S.K. (2010) Interstitial Lung Disease Associated with the Idiopathic Inflammatory Myopathies. Chest, 138, 1464-1474. https://doi.org/10.1378/chest.10-0180 |
| [2] | Guo, L., Wu, X. and Wu, X. (2023) Aspergillus Infection in Chronic Obstructive Pulmonary Diseases. The Clinical Respiratory Journal, 17, 129-138. https://doi.org/10.1111/crj.13585 |
| [3] | Opinc, A.H. and Makowska, J.S. (2021) Antisynthetase Syndrome—Much More Than Just a Myopathy. Seminars in Arthritis and Rheumatism, 51, 72-83. https://doi.org/10.1016/j.semarthrit.2020.09.020 |
| [4] | Jablonski, R., Bhorade, S., Strek, M.E. and Dematte, J. (2020) Recognition and Management of Myositis-Associated Rapidly Progressive Interstitial Lung Disease. Chest, 158, 252-263. https://doi.org/10.1016/j.chest.2020.01.033 |
| [5] | 赵转华, 叶俏, 黄慧, 等. 特发性炎性肌病相关间质性肺疾病诊断和治疗中国专家共识[J]. 中华结核和呼吸杂志, 2022, 45(7): 635-650. |
| [6] | Peshbahar, S. and Bendstrup, E. (2020) Remarkable Benefits of Intravenous Immunoglobulin (IVIG) in a Patient with Polymyositis-Associated Acute Interstitial Lung Disease. European Clinical Respiratory Journal, 7, 1840706. https://doi.org/10.1080/20018525.2020.1840706 |
| [7] | Maher, T.M., Tudor, V.A., Saunders, P., Gibbons, M.A., Fletcher, S.V., Denton, C.P., et al. (2023) Rituximab versus Intravenous Cyclophosphamide in Patients with Connective Tissue Disease-Associated Interstitial Lung Disease in the UK (RECITAL): A Double-Blind, Double-Dummy, Randomised, Controlled, Phase 2b Trial. The Lancet Respiratory Medicine, 11, 45-54. https://doi.org/10.1016/s2213-2600(22)00359-9 |
| [8] | Latgé, J. and Chamilos, G. (2019) Aspergillus fumigatus and Aspergillosis in 2019. Clinical Microbiology Reviews, 33, e00140. https://doi.org/10.1128/cmr.00140-18 |
| [9] | Ullmann, A.J., Aguado, J.M., Arikan-Akdagli, S., Denning, D.W., Groll, A.H., Lagrou, K., et al. (2018) Diagnosis and Management of Aspergillus Diseases: Executive Summary of the 2017 ESCMID-ECMM-ERS Guideline. Clinical Microbiology and Infection, 24, e1-e38. https://doi.org/10.1016/j.cmi.2018.01.002 |
| [10] | Ghanbar, M.I. and Danoff, S.K. (2024) Review of Pulmonary Manifestations in Antisynthetase Syndrome. Seminars in Respiratory and Critical Care Medicine, 45, 365-385. https://doi.org/10.1055/s-0044-1785536 |
| [11] | Shen, D., Lyu, X., Zhang, H., Fei, C., Feng, J., Zhou, J., et al. (2024) Association between Clinical Characteristics and Microbiota in Bronchiectasis Patients Based on Metagenomic Next-Generation Sequencing Technology. Polish Journal of Microbiology, 73, 59-68. https://doi.org/10.33073/pjm-2024-007 |
